Boots Recalls Paracetamol Due to Packaging Error

March 5, 2025
2 mins read
A box of Boots Paracetamol 500mg Tablets with 16 tablets inside. The packaging has the "Boots" logo at the top. Photo Source: (Gov.uk)
A box of Boots Paracetamol 500mg Tablets with 16 tablets inside. The packaging has the "Boots" logo at the top. Photo Source: (Gov.uk)

Boots has issued an urgent recall for certain packs of its own-brand paracetamol due to a serious packaging error that could pose risks to patients.

The UK Medicines and Healthcare products Regulatory Agency (MHRA) announced on March 4 that specific batches of Boots Paracetamol 500mg Tablets are being recalled because the foil blister inside the carton incorrectly states ‘Aspirin 300mg Dispersible Tablets’ instead of ‘Paracetamol 500mg Tablets’.

While the tablets themselves are confirmed to be paracetamol, the mislabeling could lead to confusion and potential health risks, especially for those with aspirin allergies or other medical conditions where aspirin is not recommended.

Affected Products

The recall specifically affects Boots Paracetamol 500mg Tablets 16s with:

  • Item code: 81-99-922
  • Batch number: 241005
  • Expiry date: December 2029

119,964 packs are affected by this recall, according to the MHRA.

Dr. Stephanie Millican, MHRA Deputy Director Benefit Risk Evaluation, emphasized the importance of checking packaging: “Patient safety is always our priority. It is vitally important that you check the packaging of your Boots Paracetamol 500mg Tablets 16s, and if the batch number is 241005, you should stop using the product and return it to a Boots store for a full refund.”


Similar Posts


What to Do

Customers who have purchased the affected product are advised to:

  1. Stop using the product immediately
  2. Return it to any Boots store for a full refund (no receipt required)
  3. Not keep the affected packs at home, even if aware of the error, as this could lead to confusion and incorrect dosing

Those who have already taken tablets from the affected batch should seek advice from a healthcare professional if they have concerns or have experienced any side effects.

“If you have purchased this product for someone else, you should inform them as soon as possible,” the MHRA advised.

Investigation Underway

Boots and the supplier, Aspar Pharmaceuticals Limited, have confirmed the tablets in the blister packs are indeed paracetamol 500mg and not aspirin. Both companies are conducting a full investigation into how the packaging error occurred.

This type of recall is classified as a Class 2 Medicines Recall by the MHRA.

According to the NHS, both paracetamol and aspirin are common painkillers but work differently in the body. Paracetamol may be better for headaches, toothache, sprains, and stomach ache, while aspirin may be better for period pain or migraines. Aspirin works by stopping the body from making compounds called prostaglandins, which helps lower pain and reduce swelling and fever.

The MHRA encourages patients who experience any suspected adverse reactions to report them via the MHRA Yellow Card Scheme, which monitors the safety of medicines in the UK.

FAQs

How do I check if my Boots paracetamol is affected by the recall?

Look for the batch number 241005 on the bottom of the box. The affected products are Boots Paracetamol 500mg Tablets 16s with item code 81-99-922 and expiry date December 2029.

What should I do if I have the recalled paracetamol?

Stop using the product immediately and return it to any Boots store for a full refund. You don’t need a receipt to get the refund.

Are the tablets themselves dangerous?

The tablets are confirmed to be paracetamol 500mg, not aspirin. The issue is with the incorrect labeling on the foil blister pack, which could lead to confusion about what medication you’re taking.

What if I’ve already taken tablets from the affected pack?

If you’ve taken tablets and are concerned or have experienced any side effects, seek advice from a healthcare professional. You can also report any suspected adverse reactions via the MHRA’s Yellow Card Scheme.

Why is this mislabeling a health concern?

The mislabeling could cause confusion about which medication you’re taking. This is particularly concerning for people who have allergies to aspirin or medical conditions where aspirin is contraindicated. It could also lead to incorrect dosing.

How many packs are affected by this recall?

According to the MHRA, 119,964 packs of Boots Paracetamol 500mg Tablets are affected by this recall.

Tejal Somvanshi

Meet Tejal Somvanshi, a soulful wanderer and a staunch wellness advocate, who elegantly navigates through the enchanting domains of Fashion and Beauty with a natural panache. Her journey, vividly painted with hues from a vibrant past in the media production world, empowers her to carve out stories that slice through the cacophony, where brands morph into characters and marketing gimmicks evolve into intriguing plot twists. To Tejal, travel is not merely an activity; it unfolds as a chapter brimming with adventures and serendipitous tales, while health is not just a regimen but a steadfast companion in her everyday epic. In the realms of fashion and beauty, she discovers her muse, weaving a narrative where each style narrates a story, and every beauty trend sparks a dialogue. Tejal seamlessly melds the spontaneous spirit of the media industry with the eloquent prose of a storyteller, crafting tales as vibrant and dynamic as the industry she thrives in.

Leave a Reply

Your email address will not be published.

Representative Image. Governor Moore attends the NAACP Convention In Las Vegas by Elijah Williamson at Mandalay Bay Convention Center, Las Vegas, NV. Photo Source: Maryland GovPics (CC BY 2.0)
Previous Story

Hazel Dukes, Former NAACP President, Dies at 92

Next Story

Joy Luck Dried Lily Flowers Recalled for Undeclared Sulfites

Latest from Health

Represntative image: Drug Capsules Photo Source: fda.gov

FDA Recalls Vitality Capsules Over Hidden ED Drugs

One Source Nutrition has issued a voluntary nationwide recall of all Vitality male enhancement capsules after FDA tests found them to contain sildenafil and tadalafil – prescription drugs used to treat erectile
Representative Image. Glenmark building, blue glass facade. Photo Source: Glenmark Pharma.

Glenmark Recalls 1.5M ADHD Drug Bottles Over Carcinogen Risk

Glenmark Pharmaceuticals has recalled approximately 1.5 million bottles of Atomoxetine Capsules from the US market after tests found potentially harmful impurities above FDA-approved limits. The medication, used to treat attention deficit hyperactivity
The man operating a medical or cosmetic laser device, performing a procedure requiring hygiene and safety precautions. Photo Source: Pexels (Pavel Danilyuk)

Bowel Cancer Rates Soar Among Young Australians

Bowel cancer rates in young Australians have more than doubled since 2000, with experts suggesting diet choices and environmental factors may be behind the alarming trend. The disease has become the deadliest

Don't Miss

Representative Image: Hyundai ix35 II facelift.

Hyundai Recalls 8,794 ix35 SUVs (2012-2013) for Fire Risk

Hyundai has issued an urgent recall for almost